Fibroblast Growth Factor Receptor‐2 Mutations in Craniosynostosis a
Fibroblast Growth Factor Receptor‐2 Mutations in Craniosynostosis a
复制标题
DOI:
10.1111/j.1749-6632.1996.tb56255.x
复制
发表时间:
1996-06
影响因子:
5.2
通讯作者:
S. Malcolm;W. Reardon
中科院分区:
文献类型:
--
作者:
S. Malcolm;W. Reardon
Mutations in the human fibroblast growth factor receptor 2 (FGFR2) gene result in several different genetically defined syndromes; Crouzon, Pfeiffer, Apert, and Jackson-Weiss. All these syndromes, which are dominantly inherited, involve craniosynostosis, or premature fusion of the cranial sutures. However, there is variable involvement of digits, from normal fingers and toes in Crouzon syndrome to severe syndactyly of the hands and feet in Apert syndrome. Fibroblast growth factor receptors are transmembrane signaling molecules with three extracellular immunoglobulin (Ig)-like domains. Two puzzling features are that identical nucleotide changes have been found in Crouzon and Pfeiffer syndromes and, secondly, that a very similar phenotype of Pfeiffer syndrome can be caused by mutations in either FGFRl and FGFR2. Mutations are found in the IgII-IgIII linker (Pfeiffer, Apert), but predominantly in the third IgIII domain. In Crouzon syndrome many mutations have been reported, but they are often recurrent and of four major types: removal of one of the cysteines from the IgIII loop, missense mutations of highly conserved residues near the cysteine, creation of new cysteines, and splice mutations. A genetic approach has been very revealing in elucidating the role of these molecules.